{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:19:02Z","timestamp":1787872742706,"version":"build-2784847793"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":99,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China General Project","award":["82274501"],"award-info":[{"award-number":["82274501"]}]},{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["2308085MH291"],"award-info":[{"award-number":["2308085MH291"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52639-9","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:46:50Z","timestamp":1779353210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["m\u2076A-associated GAS6 expression is associated with pathogenic activation of fibroblast-like synoviocytes in rheumatoid arthritis"],"prefix":"10.1038","volume":"16","author":[{"given":"Shu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MengYuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoJun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"7","key":"52639_CR1","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/art.40504","volume":"70","author":"J Falconer","year":"2018","unstructured":"Falconer, J. et al. Review: Synovial cell metabolism and chronic inflammation in rheumatoid arthritis. Arthritis Rheumatol. 70(7), 984\u2013999. https:\/\/doi.org\/10.1002\/art.40504 (2018).","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"52639_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.70167","volume":"28","author":"S Li","year":"2025","unstructured":"Li, S., Fang, H., Wan, L. & Zhang, X. Unraveling the dual role of circ-CBLB and ETS-1 in rheumatoid arthritis: Biomarkers and therapeutic targets. Int. J. Rheum. Dis. 28(3), e70167. https:\/\/doi.org\/10.1111\/1756-185X.70167 (2025).","journal-title":"Int. J. Rheum. Dis."},{"issue":"1","key":"52639_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok, B. & Firestein, G. S. Fibroblast-like synoviocytes: Key effector cells in rheumatoid arthritis. Immunol. Rev. 233(1), 233\u201355. https:\/\/doi.org\/10.1111\/j.0105-2896.2009.00859.x (2010).","journal-title":"Immunol. Rev."},{"issue":"6","key":"52639_CR4","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","volume":"16","author":"G Nygaard","year":"2020","unstructured":"Nygaard, G. & Firestein, G. S. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat. Rev. Rheumatol. 16 (6), 316\u2013333. (2020).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"12","key":"52639_CR5","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1002\/art.43268","volume":"77","author":"X Tang","year":"2025","unstructured":"Tang, X. et al. Efferocytosis and its role in rheumatic diseases. Arthritis Rheumatol. 77(12), 1635\u20131650. https:\/\/doi.org\/10.1002\/art.43268 (2025).","journal-title":"Arthritis Rheumatol."},{"key":"52639_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00742","volume":"9","author":"CEJ Waterborg","year":"2018","unstructured":"Waterborg, C. E. J. et al. Protective role of the MER Tyrosine Kinase via efferocytosis in rheumatoid arthritis models. Front. Immunol. 9, 742. https:\/\/doi.org\/10.3389\/fimmu.2018.00742 (2018).","journal-title":"Front. Immunol."},{"issue":"8","key":"52639_CR7","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/s41591-020-0939-8","volume":"26","author":"S Alivernini","year":"2020","unstructured":"Alivernini, S. et al. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat. Med. 26(8), 1295\u20131306. https:\/\/doi.org\/10.1038\/s41591-020-0939-8 (2020).","journal-title":"Nat. Med."},{"issue":"1","key":"52639_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46564-6","volume":"15","author":"A Nerviani","year":"2024","unstructured":"Nerviani, A. et al. Axl and MerTK regulate synovial inflammation and are modulated by IL-6 inhibition in rheumatoid arthritis. Nat. Commun. 15(1), 2398. https:\/\/doi.org\/10.1038\/s41467-024-46564-6 (2024).","journal-title":"Nat. Commun."},{"key":"52639_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9690832","volume":"2020","author":"J Vullings","year":"2020","unstructured":"Vullings, J. et al. Selective increment of synovial soluble TYRO3 correlates with disease severity and joint inflammation in patients with rheumatoid arthritis. J. Immunol. Res. 2020, 9690832. https:\/\/doi.org\/10.1155\/2020\/9690832 (2020).","journal-title":"J. Immunol. Res."},{"issue":"11","key":"52639_CR10","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.1016\/j.apsb.2025.08.022","volume":"15","author":"C Huang","year":"2025","unstructured":"Huang, C. et al. The epigenetic landscape of rheumatoid arthritis: Pathogenesis and drug therapeutic potentials. Acta Pharm. Sin. B 15(11), 5601\u20135631. https:\/\/doi.org\/10.1016\/j.apsb.2025.08.022 (2025).","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"52639_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-025-02034-3","volume":"74","author":"J Wen","year":"2025","unstructured":"Wen, J., Liu, J., Wan, L., Sun, Y. & Wang, F. Crosstalk between N6-methyladenosine modification and ncRNAs in rheumatic diseases: Therapeutic and diagnostic implications. Inflamm. Res. 74(1), 79. https:\/\/doi.org\/10.1007\/s00011-025-02034-3 (2025).","journal-title":"Inflamm. Res."},{"issue":"4","key":"52639_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3892\/etm.2024.12664","volume":"28","author":"Z Zhu","year":"2024","unstructured":"Zhu, Z. & Wan, L. N6-methyladenosine methyltransferase METTL14 is associated with macrophage polarization in rheumatoid arthritis. Exp. Ther. Med. 28 (4), 375. (2024).","journal-title":"Exp. Ther. Med."},{"key":"52639_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1601259","volume":"16","author":"D Yan","year":"2025","unstructured":"Yan, D. & Wan, L. WTAP modulates macrophage polarization in rheumatoid arthritis by targeting exosomal circ-CBLB via m6A modification. Front. Immunol. 16, 1601259. https:\/\/doi.org\/10.3389\/fimmu.2025.1601259 (2025).","journal-title":"Front. Immunol."},{"issue":"9","key":"52639_CR14","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1002\/art.27580","volume":"62","author":"T Neogi","year":"2010","unstructured":"Neogi, T. et al. The 2010 American College of Rheumatology\/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report. Arthritis Rheum. 62(9), 2582\u201391. https:\/\/doi.org\/10.1002\/art.27580 (2010).","journal-title":"Arthritis Rheum."},{"issue":"1","key":"52639_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/art.30100","volume":"63","author":"MP van der Linden","year":"2011","unstructured":"van der Linden, M. P., Knevel, R., Huizinga, T. W. & van der Helm-van Mil, A. H. Classification of rheumatoid arthritis: Comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology\/European League Against Rheumatism criteria. Arthritis Rheum. 63(1), 37\u201342. https:\/\/doi.org\/10.1002\/art.30100 (2011).","journal-title":"Arthritis Rheum."},{"issue":"9","key":"52639_CR16","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1002\/art.21235","volume":"52","author":"D Aletaha","year":"2005","unstructured":"Aletaha, D. et al. Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity states. Arthritis Rheum. 52(9), 2625\u201336. https:\/\/doi.org\/10.1002\/art.21235 (2005).","journal-title":"Arthritis Rheum."},{"issue":"1","key":"52639_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-024-03290-0","volume":"26","author":"G Li","year":"2024","unstructured":"Li, G., Fang, Y., Xu, N., Ding, Y. & Liu, D. Fibroblast-like synoviocytes-derived exosomal circFTO deteriorates rheumatoid arthritis by enhancing N6-methyladenosine modification of SOX9 in chondrocytes. Arthritis Res. Ther. 26(1), 56. https:\/\/doi.org\/10.1186\/s13075-024-03290-0 (2024).","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"52639_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10863-024-10035-w","volume":"56","author":"X Liu","year":"2024","unstructured":"Liu, X., Xia, Z., Liu, L. & Ren, D. WTAP promotes fibroblast-like synoviocyte pyroptosis in rheumatoid arthritis by upregulating N6-methyladenosine modification of NLRP3. J. Bioenerg. Biomembr. 56(5), 563\u2013571. https:\/\/doi.org\/10.1007\/s10863-024-10035-w (2024).","journal-title":"J. Bioenerg. Biomembr."},{"issue":"1","key":"52639_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-025-00434-z","volume":"13","author":"Q Geng","year":"2025","unstructured":"Geng, Q. et al. IGF2BP3-mediated m6A modification of RASGRF1 promoting joint injury in rheumatoid arthritis. Bone Res. 13(1), 51. https:\/\/doi.org\/10.1038\/s41413-025-00434-z (2025).","journal-title":"Bone Res."},{"issue":"1","key":"52639_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41420-024-01988-3","volume":"10","author":"Y Nan","year":"2024","unstructured":"Nan, Y. et al. IGF2BP2 regulates the inflammation of fibroblast-like synoviocytes via GSTM5 in rheumatoid arthritis. Cell Death Discov. 10(1), 215. https:\/\/doi.org\/10.1038\/s41420-024-01988-3 (2024).","journal-title":"Cell Death Discov."},{"key":"52639_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1556764","volume":"16","author":"F Wang","year":"2025","unstructured":"Wang, F. et al. Demethylase FTO mediates m6A modification of ENST00000619282 to promote apoptosis escape in rheumatoid arthritis and the intervention effect of Xinfeng Capsule. Front. Immunol. 16, 1556764. https:\/\/doi.org\/10.3389\/fimmu.2025.1556764 (2025).","journal-title":"Front. Immunol."},{"key":"52639_CR22","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3389\/fimmu.2019.00705","volume":"10","author":"MG Dorrington","year":"2019","unstructured":"Dorrington, M. G. & Fraser, I. D. C. NF-\u03baB signaling in macrophages: Dynamics, crosstalk, and signal integration. Front. Immunol. 10, 705. https:\/\/doi.org\/10.3389\/fimmu.2019.00705 (2019).","journal-title":"Front. Immunol."},{"issue":"1","key":"52639_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01133-0","volume":"21","author":"L Gao","year":"2023","unstructured":"Gao, L. et al. Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis. Cell Commun. Signal. 21(1), 195. https:\/\/doi.org\/10.1186\/s12964-023-01133-0 (2023).","journal-title":"Cell Commun. Signal."},{"issue":"8","key":"52639_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084404","volume":"25","author":"KC Lahey","year":"2024","unstructured":"Lahey, K. C. et al. Regulation of Mertk surface expression via ADAM17 and \u03b3-secretase proteolytic processing. Int. J. Mol. Sci. 25(8), 4404. https:\/\/doi.org\/10.3390\/ijms25084404 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"52639_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36468-2","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. Remodeling articular immune homeostasis with an efferocytosis-informed nanoimitator mitigates rheumatoid arthritis in mice. Nat. Commun. 14(1), 817. https:\/\/doi.org\/10.1038\/s41467-023-36468-2 (2023).","journal-title":"Nat. Commun."},{"issue":"28","key":"52639_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404198","volume":"11","author":"S Yuan","year":"2024","unstructured":"Yuan, S. et al. Engineering efferocytosis-mimicking nanovesicles to regulate joint anti-inflammation and peripheral immunosuppression for rheumatoid arthritis therapy. Adv. Sci. 11(28), e2404198. https:\/\/doi.org\/10.1002\/advs.202404198 (2024).","journal-title":"Adv. Sci."},{"key":"52639_CR27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.actbio.2025.03.023","volume":"197","author":"X Zhong","year":"2025","unstructured":"Zhong, X. et al. Immuno-engineered macrophage membrane-coated nanodrug to restore immune balance for rheumatoid arthritis treatment. Acta Biomater. 197, 374\u2013385. https:\/\/doi.org\/10.1016\/j.actbio.2025.03.023 (2025).","journal-title":"Acta Biomater."},{"key":"52639_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1785209","volume":"17","author":"S Li","year":"2026","unstructured":"Li, S., Wan, L. & Zhang, X. The PANoptotic mosaic of rheumatoid arthritis: Epitranscriptomic regulation, systemic relays, and precision death-mode editing. Front. Immunol. 17, 1785209. https:\/\/doi.org\/10.3389\/fimmu.2026.1785209 (2026).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52639-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52639-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52639-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:54:11Z","timestamp":1787871251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52639-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52639"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52639-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7993179\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"31 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics Committee of the Affiliated Hospital of Anhui University of Chinese Medicine (Approval No: 2023AH-52; Approval Date: July 27, 2023). All methods were performed in accordance with the relevant guidelines and regulations, including the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Institutional review board statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all enrolled patients.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was granted by the Ethics Committee of the First Affiliated Hospital of Anhui University of Chinese Medicine.","order":4,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26987"}}